Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Aerosol Cyclosporine for Prevention of Lung Rejection

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00268515
First received: December 21, 2005
Last updated: May 12, 2016
Last verified: December 2005